AI is actively transforming academic otolaryngology by enhancing clinical operations, resident education, and recruitment processes. The Society of University Otolaryngologists Annual Meeting in 2025 highlighted practical AI applications improving efficiency and outcomes in the field.
TXA is increasingly used in otolaryngology to reduce intra-operative and post-operative bleeding, supported by evidence from emergency medicine and orthopedic surgery. Its safety profile is strong, and it is administered intravenously or orally, with emerging use in pediatric and adult otolaryngologic procedures.
Can peer reviewers and editors reliably detect AI-generated manuscripts in scientific publishing?
Otolaryngologists discuss significant changes in their practices, highlighting advancements in technology, challenges with insurance, and evolving patient communication methods.
Patient advocacy organizations like the Chordoma Foundation and SMARCB1 Hope play a crucial role in supporting patients with rare sinonasal and skull base tumors by providing resources, fostering research, and building community connections. Their efforts highlight the importance of collaboration between patients, clinicians, and researchers to improve outcomes and care.
